Risperdal Gynecomastia Lawsuit Meeting Scheduled for August 6th, Notes Hissey Kientz, LLP

Share Article

Patients that have allegedly suffered from gynecomastia after taking Risperdal can contact Hissey Kientz, LLP for a free legal consultation.

News Image

The Pennsylvania state court will hold a meeting on Wednesday, August 6th to discuss lawsuits related to male gynecomastia and other side effects stemming from Risperdal use, Hissey Kientz, LLP reports. According to court documents, over 600 Risperdal lawsuits have been filed in a Mass Tort litigation underway in Pennsylvania's Philadelphia Court of Common Pleas. (Risperdal Litigation, case number 100300296)

The National Center for Biotechnology Information defines gynecomastia as the enlargement of breast tissue in males. An estimated 10%-25% of gynecomastia cases result from the use of medications. Side effects from gynecomastia can include swollen breast gland tissue, breast tenderness and lactation in one or both breasts.*

A 2006 study published in the Journal of Clinical Psychopharmacology reported that adolescents who took Risperdal exhibited significantly high levels of the hormone prolactin, which stimulates milk production and breast development. High levels of prolactin can lead to gynecomastia for men.**

A 2009 study published in the Journal of Child and Adolescent Psychopharmacology found that elevated prolactin levels from Risperdal use could persist for two years.***

Patients who have experienced gynecomastia from Risperdal use may wish to speak with a lawyer to find out if they are eligible to file a lawsuit. For more information about whether you may have a case, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by email at info(at)hkllp(dot)com.

** http://www.ncbi.nlm.nih.gov/pubmed/16633146
*** http://www.ncbi.nlm.nih.gov/pubmed/19702492

About Hissey Kientz, LLP
Hissey Kientz, LLP (http://www.hkllp.com) represents individuals experiencing breast growth from Risperdal, as well as victims of mesothelioma and other asbestos-related diseases, birth defects linked to the antidepressant drugs Zoloft, Lexapro, Celexa and Effexor, problems with transvaginal mesh, Stryker, DePuy, and Biomet hip replacements, GranuFlo acid concentrates, Mirena IUDs and other defective drugs and medical devices.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Allison Sass
Hissey Kientz, LLP
since: 12/2010
Like >
Follow us on
Visit website